Median Technologies · EURONEXT:ALMDT
Median Technologies — Cowen 37th Annual Health Care Conference 2017
20 slides from Median Technologies's conference presentation, Mar 6, 2017
Slide 1: Median Technologies Presentation
Median Technologies Presentation Fredrik Brag, CEO COWEN 37th Annual Health Care Conference March 6 – 8, 2017 - Boston, Massachusetts Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA
Slide 2: Disclaimer
Disclaimer Median Technologies, its directors, officers, advisors and employees make no representation or warranty as to statistical data or predictions contained in this presentation that were taken or derived from third party sources or industry publications; such statistical data and forecasts ar
Slide 3: Why we do what we do…
Why we do what we do… “At Median we see the person on the other end of the images” Global Imaging Solutions for detection, diagnosis and monitoring of diseases A simple vision: ‘’if we can spot and track a tank from space, we can spot and track a tumor.” Saw a trend: imaging is critical for diag
Slide 4: Our origin, our history
Our origin, our history The Imaging Phenomics™ Company Medical image analysis is what we do and what we have always done since 2002. Precision Medicine refers to the tailoring of medical Extracting the most meaning out of an image treatment to the individual characteristics of each patient. Rece
Slide 5: Bringing the power of Imaging Phenomics to the entire patient journey
Bringing the power of Imaging Phenomics™ to the entire patient journey IMAGING FOR CLINICAL TRIALS IMAGING FOR PATIENT CARE Advancing treatments of the future Identifying treatments that work Working with biopharmaceutical companies and leading medical Imaging biomarkers provide a unique insights in
Slide 6: Median is applying technology to enable cancer treatment
Median is applying technology to enable cancer treatment After many years of research and some advances, cancer continues to be the one of the top 2 causes of death in the United States1, EU2, and China3. Most of the new immuno-oncology treatments still only have about 20% responders4 The indu
Slide 7: Part 1: A Disruptive Technology
Part 1: A Disruptive Technology Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA 7
Slide 8: Lesion Management Solution (LMS)
Lesion Management Solution (LMS) Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA 8
Slide 9: Median iBiopsy platform
Median iBiopsy™ platform Proprietary & patented cloud-based AI technology & processes iBiopsy™ is a high-throughput, comprehensive, accurate, end-to-end image retrieval and analysis platform for large scale extraction of imaging biomarkers and phenotypic signatures. iBiopsy™ is based on state-of-the
Slide 10: Median iBiopsy platform
Median iBiopsy™ platform Mapping imaging signatures to patho-histology Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA 10
Slide 11: Median iBiopsy platform
Median iBiopsy™ platform Initial target applications for liver, lung, prostate The Liver image is automatically A tissue classification map is Example of an iBiopsy™ application is for the assessment of Non Alcoholic Fatty Liver Diseases 1| segmented in ‘tiles’ with a unique signature computed to ea
Slide 12: Patenting Timeline 2017
Patenting Timeline 2017 iBiopsy™ Core Technology Q1 – Q3 Neural Network for Content Based Medical Image Medical Image iBiopsy™ Classification Retrieval System Big Data System Deep Learning Cloud Computing System iBiopsy™ Clinical Apps Q2 – Q4 Tumor Fibrosis Microenvironment Measurement Immunotherapy
Slide 13: Part 2: Business Development
Part 2: Business Development Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA 13
Slide 14: Market opportunities
Market opportunities CLINICAL TRIALS PATIENT CARE Improve and optimize the Improve screening, diagnosis assessment of new cancer and monitoring standards TARGET MARKETS drugs in clinical trials of cancer patients MARKET PLAYERS +$1bn annual market Multi $Bn market Biopharma companies Governm
Slide 15: Partnerships and Collaborations
Partnerships and Collaborations “Partnering for the Patients” Commercial We work with thought leaders and top PATIENT CARE CLINICAL TRIALS innovators in healthcare to deliver a seamless service in all fields of our Collaborations work. with global Contract Research Collaboration with KOL’s and maj
Slide 16: iBiopsy market potential
iBiopsy™ market potential Target applications and companion diagnostics There are more than 600m imaging procedures in the US alone. The Precision Medicine Market is expected to be over $80bn by 2020. iBiopsy™ value proposition: Patient selection for targeted therapies Early detection of c
Slide 17: Part 3: Corporate Milestones
Part 3: Corporate Milestones Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA 17
Slide 18: Executive team: recent appointments
Executive team: recent appointments All based in the United States Jeanne Hecht Nicholas Campbell James Golando as Chief Operating Officer as Chief Commercial Officer as Chief of Operations Cowen 37th Annual Health Care Conference - March 6-8, 2017 - Boston, MA 18
Slide 19: Scanning the horizon
Scanning the horizon Harnessing the power of Imaging Phenomics™ Median can revolutionize cancer care by: Diagnosing cancer at an early stage: Example, identify phenotype for early stage lung cancer screening Changing the way we diagnose & treat cancer: Collaborate on phenotype indexing and ‘Deep
Slide 20: Median Technologies HQ
Median Technologies HQ Les Deux Arcs – Bât B 1800, Route des Crêtes 06560 Valbonne – France Median Technologies Inc 300 TradeCenter Suite 5610 Woburn MA 01801 – USA www.mediantechnologies.com Fredrik.brag@mediantechnologies.com investors@mediantechnologies.com Cowen 37th Annual Health Care Conferenc
Median Technologies — Cowen 37th Annual Health Care Conference 2017 on 6ix